Survey: Patients still face medication access barriers despite prior authorization reforms
National patient survey finds cost confusion, prior authorization delays can derail care, but technology can unlock price transparency, improv access
Pharmacy
PCMA files lawsuit to stop harmful Tennessee forced pharmacy closure legislation
"By forcing the closure of more than 160 PBM-affiliated retail, specialty, and mail-order pharmacies across the state, lawmakers are creating harmful new barriers for patients."
Long-term benefit of PBMs’ moves is uncertain
The test will be whether the shifts bring savings and less complexity for patients and pharmacies.
PRI report warns of risks tied to unauthorized GLP-1 knockoffs
A new Pacific Research Institute report warns that unauthorized compounded GLP-1 drugs may pose patient safety risks and hinder future pharmaceutical innovation.
Gilead mobilizes rapid donation of remdesivir to support Ebola response
Building on decade-long commitment to outbreak relief.
On the menu at Grocers: Simple, sustainable changes to boost health
Benefits from high-fiber foods include lower cholesterol, more balanced blood sugar levels and improved energy levels.
Amneal announces full study population interim Phase 4 ELEVATE-PD results, reinforcing previously reported benefits of CREXONT in Parkinson's Disease
Phase 4 ELEVATE-PD interim data from the entire study population (n=214) continue to show clinically meaningful, consistent benefits of CREXONT across all prior treatment groups.
Shaq teams with Lilly to spotlight sleep apnea treatment with Zepbound
“Being prescribed Zepbound helped make a difference for me in my OSA treatment journey; I even lost some weight,” O’Neal said.
NACDS updates members on CMS Medicare GLP-1 Bridge Program rollout
NACDS is advising chain pharmacy members on the upcoming launch of the CMS Medicare GLP-1 Bridge Program, a temporary demonstration that will provide eligible Medicare beneficiaries with access to certain medications beginning July 1.
Supreme Court rules in Hikma's favor in 'skinny' label case
The court unanimously ruled that Hikma's generic version of Amarin’s cardiovascular drug Vascepa (icosapent ethyl) does not infringe on the branded drug maker's patents.
PBIRx hosts webinar: Biosimilars - The New Savings Frontier for Prescription Drug Benefits
The panel shared trends and tools to optimize biosimilar adoption to lower plan costs while supporting optimal health outcomes for members.
NACDS promotes Kayla McFeely to SVP, Health and Wellness Strategy and Policy
From Executive Fellow to senior leadership, McFeely has helped shape NACDS’ vision for the future of pharmacy-based care.
Robotics power CVS supply chain modernization
CVS Pharmacy uses robotics and automation at its Hainesport, N.J., center to improve inventory, speed store replenishment, and boost supply chain efficiency.
NACDS president and CEO Steven Anderson receives the association profession's highest honor – The ASAE Key Award
Prestigious recognition salutes career of transformational leadership.
NACDS commends The Washington Post editorial board for endorsing pharmacist scope-of-practice modernization
Editorial spotlighting Alaska's HB 195 reinforces a national case for letting pharmacists practice at the top of their education.